当前蛋白身份:P27695 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1BIX THE CRYSTAL STRUCTURE OF THE HUMAN DNA REPAIR ENDONUCLEASE HAP1 SUGGESTS THE RECOGNITION OF EXTRA-HELICAL DEOXYRIBOSE AT DNA ABASIC SITES 提交 1998-06-19 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 31–317(287 aa)
未记录 SM SAMARIUM (III) ION × 4 PT PLATINUM (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 7.4;pH 7.4
分辨率 2.20 Å R-free 0.269
1CQG HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59-71 OF THE P50 SUBUNIT OF NFKB), NMR, 31 STRUCTURES 提交 1996-04-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 58–70(13 aa) 片段:RESIDUES 59 - 71 OF THE P50 SUBUNIT OF NFKB
未记录 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
1CQH HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59-71 OF THE P50 SUBUNIT OF NFKB), NMR, MINIMIZED AVERAGE STRUCTURE 提交 1996-04-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 58–70(13 aa) 片段:RESIDUES 59 - 71 OF THE P50 SUBUNIT OF NFKB
未记录 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
1DE8 HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE-1 (APE1) BOUND TO ABASIC DNA 提交 1999-11-13 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 42–317(276 aa) 片段:APE1
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;MPEG 5000, LITHIUM SULFATE, MES BUFFER, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.95 Å R-free 0.312
1DE8 HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE-1 (APE1) BOUND TO ABASIC DNA 提交 1999-11-13 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 B 42–317(276 aa) 片段:APE1
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;MPEG 5000, LITHIUM SULFATE, MES BUFFER, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.95 Å R-free 0.312
1DE9 HUMAN APE1 ENDONUCLEASE WITH BOUND ABASIC DNA AND MN2+ ION 提交 1999-11-13 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 42–317(276 aa) 片段:APE1
未记录 MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;MPEG 2000, LITHIUM SULFATE, MANGANESE CHLORIDE, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 3.00 Å R-free 0.274
1DE9 HUMAN APE1 ENDONUCLEASE WITH BOUND ABASIC DNA AND MN2+ ION 提交 1999-11-13 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 42–317(276 aa) 片段:APE1
未记录 MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;MPEG 2000, LITHIUM SULFATE, MANGANESE CHLORIDE, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 3.00 Å R-free 0.274
1DEW CRYSTAL STRUCTURE OF HUMAN APE1 BOUND TO ABASIC DNA 提交 1999-11-15 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 B 39–317(279 aa) 片段:APE1
未记录 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;MPEG 2000, LITHIUM SULFATE, CACODYLATE BUFFER, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.65 Å R-free 0.286
1DEW CRYSTAL STRUCTURE OF HUMAN APE1 BOUND TO ABASIC DNA 提交 1999-11-15 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 39–317(279 aa) 片段:APE1
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;MPEG 2000, LITHIUM SULFATE, CACODYLATE BUFFER, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.65 Å R-free 0.286
1E9N A second divalent metal ion in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1, and its implications for the catalytic mechanism 提交 2000-10-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–317(317 aa)
未记录 PB LEAD (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;HANGING DROP, DROP 2+2 UL, 15MG/ML PROTEIN, 1 ML WELL, 0.1M TRIS-HCL, PH 7.5, 0.2M NAOAC, 30% PEG4K, 20MM HECAMEG, 1MM PB(OAC)2, 1MM DTT
分辨率 2.20 Å R-free 0.252
1E9N A second divalent metal ion in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1, and its implications for the catalytic mechanism 提交 2000-10-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–317(317 aa)
未记录 PB LEAD (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;HANGING DROP, DROP 2+2 UL, 15MG/ML PROTEIN, 1 ML WELL, 0.1M TRIS-HCL, PH 7.5, 0.2M NAOAC, 30% PEG4K, 20MM HECAMEG, 1MM PB(OAC)2, 1MM DTT
分辨率 2.20 Å R-free 0.252
1HD7 A Second Divalent Metal Ion in the Active Site of a New Crystal Form of Human Apurinic/Apyridinimic Endonuclease, Ape1, and its Implications for the Catalytic Mechanism 提交 2000-11-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–317(317 aa)
未记录 PB LEAD (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 4.5;0.1M NAOAC PH 4.6, 25% PEG 4K, 1 MM PB(II)OAC, 10-12 MG/ML PROTEIN.
分辨率 1.95 Å R-free 0.255
2ISI Crystal structure of Ape1 from Homo sapiens in a new crystal form complexed with a ligand 提交 2006-10-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–317(317 aa)
未记录 PO4 PHOSPHATE ION × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 7.5;277 K;0.1M hepes, 70% MPD, pH 7.5, VAPOR DIFFUSION, temperature 277K
分辨率 2.76 Å R-free 0.284
2ISI Crystal structure of Ape1 from Homo sapiens in a new crystal form complexed with a ligand 提交 2006-10-17 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–317(317 aa)
未记录 PO4 PHOSPHATE ION × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 7.5;277 K;0.1M hepes, 70% MPD, pH 7.5, VAPOR DIFFUSION, temperature 277K
分辨率 2.76 Å R-free 0.284
2ISI Crystal structure of Ape1 from Homo sapiens in a new crystal form complexed with a ligand 提交 2006-10-17 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–317(317 aa)
未记录 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 7.5;277 K;0.1M hepes, 70% MPD, pH 7.5, VAPOR DIFFUSION, temperature 277K
分辨率 2.76 Å R-free 0.284
2O3H Crystal structure of the human C65A Ape 提交 2006-12-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 39–317(279 aa)
突变:C65A SM SAMARIUM (III) ION × 2 ACT ACETATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;20% PEG 8000, 100 mM MES pH 6.0, 7.5 mM samarium acetate, 4% dioxane, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.90 Å R-free 0.226
3U8U Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form 提交 2011-10-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–318(318 aa)
未记录 MG MAGNESIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;280 K;0.05M MGCL2.6H2O, 0.1M HEPES PH 7.5, 30% PEG 550MME, 1 MICRO-MOLAR HYCANTHONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 280K
分辨率 2.15 Å R-free 0.243
3U8U Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form 提交 2011-10-17 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
未记录 MG MAGNESIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;280 K;0.05M MGCL2.6H2O, 0.1M HEPES PH 7.5, 30% PEG 550MME, 1 MICRO-MOLAR HYCANTHONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 280K
分辨率 2.15 Å R-free 0.243
3U8U Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form 提交 2011-10-17 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–318(318 aa)
未记录 MG MAGNESIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;280 K;0.05M MGCL2.6H2O, 0.1M HEPES PH 7.5, 30% PEG 550MME, 1 MICRO-MOLAR HYCANTHONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 280K
分辨率 2.15 Å R-free 0.243
3U8U Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form 提交 2011-10-17 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–318(318 aa)
未记录 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;280 K;0.05M MGCL2.6H2O, 0.1M HEPES PH 7.5, 30% PEG 550MME, 1 MICRO-MOLAR HYCANTHONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 280K
分辨率 2.15 Å R-free 0.243
3U8U Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form 提交 2011-10-17 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 1–318(318 aa)
未记录 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;280 K;0.05M MGCL2.6H2O, 0.1M HEPES PH 7.5, 30% PEG 550MME, 1 MICRO-MOLAR HYCANTHONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 280K
分辨率 2.15 Å R-free 0.243
3U8U Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form 提交 2011-10-17 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 F 1–318(318 aa)
未记录 MG MAGNESIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;280 K;0.05M MGCL2.6H2O, 0.1M HEPES PH 7.5, 30% PEG 550MME, 1 MICRO-MOLAR HYCANTHONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 280K
分辨率 2.15 Å R-free 0.243
4IEM Human apurinic/apyrimidinic endonuclease (APE1) with product DNA and Mg2+ 提交 2012-12-13 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 2–318(317 aa)
未记录 MG MAGNESIUM ION × 3 NA SODIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;50 mM MES pH 6.0, 200 mM LiSO4, and 25% mPEG 2K, vapor diffusion, hanging drop, temperature 298K
分辨率 2.39 Å R-free 0.246
4IEM Human apurinic/apyrimidinic endonuclease (APE1) with product DNA and Mg2+ 提交 2012-12-13 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 2–318(317 aa)
未记录 MG MAGNESIUM ION × 1 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;50 mM MES pH 6.0, 200 mM LiSO4, and 25% mPEG 2K, vapor diffusion, hanging drop, temperature 298K
分辨率 2.39 Å R-free 0.246
4IEM Human apurinic/apyrimidinic endonuclease (APE1) with product DNA and Mg2+ 提交 2012-12-13 Assembly 3 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 C 2–318(317 aa)
未记录 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;50 mM MES pH 6.0, 200 mM LiSO4, and 25% mPEG 2K, vapor diffusion, hanging drop, temperature 298K
分辨率 2.39 Å R-free 0.246
4IEM Human apurinic/apyrimidinic endonuclease (APE1) with product DNA and Mg2+ 提交 2012-12-13 Assembly 4 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 D 2–318(317 aa)
未记录 MG MAGNESIUM ION × 1 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;50 mM MES pH 6.0, 200 mM LiSO4, and 25% mPEG 2K, vapor diffusion, hanging drop, temperature 298K
分辨率 2.39 Å R-free 0.246
4LND Crystal structure of human apurinic/apyrimidinic endonuclease 1 with essential Mg2+ cofactor 提交 2013-07-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 39–318(280 aa) 片段:UNP residues 39-318
未记录 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;295 K;0.1 M MES pH 6.5, 30% (v/v) PEG 300, VAPOR DIFFUSION, SITTING DROP, temperature 295K
分辨率 1.92 Å R-free 0.241
4LND Crystal structure of human apurinic/apyrimidinic endonuclease 1 with essential Mg2+ cofactor 提交 2013-07-11 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 39–318(280 aa) 片段:UNP residues 39-318
未记录 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;295 K;0.1 M MES pH 6.5, 30% (v/v) PEG 300, VAPOR DIFFUSION, SITTING DROP, temperature 295K
分辨率 1.92 Å R-free 0.241
4LND Crystal structure of human apurinic/apyrimidinic endonuclease 1 with essential Mg2+ cofactor 提交 2013-07-11 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 39–318(280 aa) 片段:UNP residues 39-318
未记录 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;295 K;0.1 M MES pH 6.5, 30% (v/v) PEG 300, VAPOR DIFFUSION, SITTING DROP, temperature 295K
分辨率 1.92 Å R-free 0.241
4QH9 Crystal structure of Mn2+ bound human APE1 提交 2014-05-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 38–318(281 aa) 片段:UNP residues 38-318
突变:C138A EDO 1,2-ETHANEDIOL × 7 MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.1M MES, 0.2M Sodium Chloride, 19% PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.17 Å R-free 0.256
4QHD Crystal structure of apo human APE1 提交 2014-05-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 38–318(281 aa) 片段:UNP residues 38-318
突变:C138A EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.1M MES, 0.2M Sodium Chloride, 19% PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 1.65 Å R-free 0.238
4QHE Crystal structure of Mg2+ bound human APE1 提交 2014-05-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 38–318(281 aa)
突变:C138A MG MAGNESIUM ION × 1 EDO 1,2-ETHANEDIOL × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.1M MES, 0.2M Sodium Chlorid, 19% PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 1.40 Å R-free 0.193
5CFG C2 crystal form of APE1 with Mg2+ 提交 2015-07-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 44–318(275 aa) 片段:UNP residues 44-318
未记录 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;295 K;20% PEG 8000, 0.2 M MgAc and 0.1 M Cacodylate
分辨率 1.80 Å R-free 0.204
5DFF Human APE1 product complex 提交 2015-08-26 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
未记录 MG MAGNESIUM ION × 1 PEG DI(HYDROXYETHYL)ETHER × 1 CL CHLORIDE ION × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.57 Å R-free 0.211
5DFF Human APE1 product complex 提交 2015-08-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
未记录 PEG DI(HYDROXYETHYL)ETHER × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.57 Å R-free 0.211
5DFH Human APE1 mismatch product complex 提交 2015-08-26 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
未记录 EDO 1,2-ETHANEDIOL × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% Peg20000, 100 mM sodium citrate, 200 mM MgCl
分辨率 1.95 Å R-free 0.219
5DFH Human APE1 mismatch product complex 提交 2015-08-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% Peg20000, 100 mM sodium citrate, 200 mM MgCl
分辨率 1.95 Å R-free 0.219
5DFI Human APE1 phosphorothioate substrate complex 提交 2015-08-26 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 43–318(276 aa)
未记录 EDO 1,2-ETHANEDIOL × 4 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, 200 mM MgCl
分辨率 1.63 Å R-free 0.195
5DFI Human APE1 phosphorothioate substrate complex 提交 2015-08-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
未记录 EDO 1,2-ETHANEDIOL × 2 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, 200 mM MgCl
分辨率 1.63 Å R-free 0.195
5DFJ Human APE1 E96Q/D210N mismatch substrate complex 提交 2015-08-26 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 43–318(276 aa)
突变:E96Q, D210N CL CHLORIDE ION × 6 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, 200 mM MgCl
分辨率 1.85 Å R-free 0.200
5DFJ Human APE1 E96Q/D210N mismatch substrate complex 提交 2015-08-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:E96Q, D210N CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, 200 mM MgCl
分辨率 1.85 Å R-free 0.200
5DG0 Human APE1 phosphorothioate substrate complex with Mn2+ 提交 2015-08-27 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 43–318(276 aa) 片段:UNP residues 43-318
未记录 MN MANGANESE (II) ION × 6 EDO 1,2-ETHANEDIOL × 4 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% Peg 20000, 100 mM sodium citrate, 200 mM MgCl2
分辨率 1.80 Å R-free 0.205
5DG0 Human APE1 phosphorothioate substrate complex with Mn2+ 提交 2015-08-27 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa) 片段:UNP residues 43-318
未记录 MN MANGANESE (II) ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% Peg 20000, 100 mM sodium citrate, 200 mM MgCl2
分辨率 1.80 Å R-free 0.205
5WN0 APE1 exonuclease substrate complex with a C/G match 提交 2017-07-31 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.60 Å R-free 0.275
5WN0 APE1 exonuclease substrate complex with a C/G match 提交 2017-07-31 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.60 Å R-free 0.275
5WN1 APE1 exonuclease product complex 提交 2017-07-31 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
未记录 NA SODIUM ION × 1 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.30 Å R-free 0.270
5WN1 APE1 exonuclease product complex 提交 2017-07-31 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
未记录 CL CHLORIDE ION × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.30 Å R-free 0.270
5WN2 APE1 exonuclease substrate complex with phosphoglycolate 提交 2017-07-31 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
未记录 NA SODIUM ION × 2 EDO 1,2-ETHANEDIOL × 1 PGA 2-PHOSPHOGLYCOLIC ACID × 1 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.29 Å R-free 0.239
5WN2 APE1 exonuclease substrate complex with phosphoglycolate 提交 2017-07-31 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
未记录 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.29 Å R-free 0.239
5WN3 APE1 F266A exonuclease substrate complex with a C/T mismatch 提交 2017-07-31 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:C138A, F266A CA CALCIUM ION × 1 EDO 1,2-ETHANEDIOL × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.00 Å R-free 0.258
5WN3 APE1 F266A exonuclease substrate complex with a C/T mismatch 提交 2017-07-31 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
突变:C138A, F266A EDO 1,2-ETHANEDIOL × 2 NA SODIUM ION × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.00 Å R-free 0.258
5WN4 APE1 exonuclease substrate complex with a C/T mismatch 提交 2017-07-31 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
未记录 NA SODIUM ION × 2 CA CALCIUM ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.10 Å R-free 0.249
5WN4 APE1 exonuclease substrate complex with a C/T mismatch 提交 2017-07-31 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
未记录 NA SODIUM ION × 1 EDO 1,2-ETHANEDIOL × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.10 Å R-free 0.249
5WN5 APE1 exonuclease substrate complex with a C/T mismatch and Mn2+ 提交 2017-07-31 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
未记录 MN MANGANESE (II) ION × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.20 Å R-free 0.261
5WN5 APE1 exonuclease substrate complex with a C/T mismatch and Mn2+ 提交 2017-07-31 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
未记录 MN MANGANESE (II) ION × 1 NA SODIUM ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.20 Å R-free 0.261
6BOQ Human APE1 substrate complex with an A/A mismatch adjacent the THF 提交 2017-11-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 1–318(318 aa)
突变:C138A EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.96 Å R-free 0.258
6BOQ Human APE1 substrate complex with an A/A mismatch adjacent the THF 提交 2017-11-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
突变:C138A EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.96 Å R-free 0.258
6BOR Human APE1 substrate complex with an G/G mismatch adjacent the THF 提交 2017-11-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 1–318(318 aa)
突变:E96Q, D210N EDO 1,2-ETHANEDIOL × 3 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.84 Å R-free 0.209
6BOR Human APE1 substrate complex with an G/G mismatch adjacent the THF 提交 2017-11-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
突变:E96Q, D210N EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.84 Å R-free 0.209
6BOS Human APE1 substrate complex with an A/C mismatch adjacent the THF 提交 2017-11-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 1–318(318 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 2.30 Å R-free 0.236
6BOS Human APE1 substrate complex with an A/C mismatch adjacent the THF 提交 2017-11-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 2.30 Å R-free 0.236
6BOT Human APE1 substrate complex with an C/C mismatch adjacent the THF 提交 2017-11-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 1–318(318 aa)
突变:C138A EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 2.30 Å R-free 0.245
6BOT Human APE1 substrate complex with an C/C mismatch adjacent the THF 提交 2017-11-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 2.30 Å R-free 0.245
6BOU Human APE1 substrate complex with an T/C mismatch adjacent the THF 提交 2017-11-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 1–318(318 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 2.54 Å R-free 0.268
6BOU Human APE1 substrate complex with an T/C mismatch adjacent the THF 提交 2017-11-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 2.54 Å R-free 0.268
6BOV Human APE1 substrate complex with an A/G mismatch adjacent the THF 提交 2017-11-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 1–318(318 aa)
突变:E96Q, D210N, C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.98 Å R-free 0.242
6BOV Human APE1 substrate complex with an A/G mismatch adjacent the THF 提交 2017-11-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
突变:E96Q, D210N, C138A PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.98 Å R-free 0.242
6BOW Human APE1 substrate complex with an T/T mismatch adjacent the THF 提交 2017-11-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 1–318(318 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.59 Å R-free 0.241
6BOW Human APE1 substrate complex with an T/T mismatch adjacent the THF 提交 2017-11-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–318(318 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;7% PEG 20K, 100mM sodium Citrate, 15% glycerol, 5mM CaCl2
分辨率 1.59 Å R-free 0.241
6MK3 Crystallographic solvent mapping analysis of DMSO bound to APE1 提交 2018-09-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 40–318(279 aa) 片段:UNP residues 40-318
未记录 DMS DIMETHYL SULFOXIDE × 2 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000
分辨率 1.48 Å R-free 0.219
6MKK Crystallographic solvent mapping analysis of DMSO/Mg bound to APE1 提交 2018-09-25 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 40–318(279 aa) 片段:UNP residues 40-318
未记录 MG MAGNESIUM ION × 1 DMS DIMETHYL SULFOXIDE × 1 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000
分辨率 1.44 Å R-free 0.212
6MKM Crystallographic solvent mapping analysis of DMSO/Tris bound to APE1 提交 2018-09-25 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 40–318(279 aa) 片段:UNP residues 40-318
未记录 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 DMS DIMETHYL SULFOXIDE × 2 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000
分辨率 1.67 Å R-free 0.250
6MKO Crystallographic solvent mapping analysis of glycerol bound to APE1 提交 2018-09-25 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 40–318(279 aa) 片段:UNP residues 40-318
未记录 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000
分辨率 2.09 Å R-free 0.228
6P93 Human APE1 K98A AP-endonuclease product complex 提交 2019-06-09 Assembly 1 蛋白–DNA 同源多聚体;蛋白 × 2 PDB 声明:pentameric(5) 与全部聚合物一致
链 A 43–318(276 aa)
链 B 43–318(276 aa)
突变:K98A 突变:K98A MG MAGNESIUM ION × 1 PEG DI(HYDROXYETHYL)ETHER × 1 CL CHLORIDE ION × 1 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 2.10 Å R-free 0.226
6P94 Human APE1 C65A AP-endonuclease product complex 提交 2019-06-09 Assembly 1 蛋白–DNA 同源多聚体;蛋白 × 2 PDB 声明:pentameric(5) 与全部聚合物一致
链 A 43–318(276 aa)
链 B 43–318(276 aa)
未记录 MG MAGNESIUM ION × 1 PEG DI(HYDROXYETHYL)ETHER × 1 CL CHLORIDE ION × 1 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 2.09 Å R-free 0.244
6W0Q APE1 endonuclease product complex D148E 提交 2020-03-02 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
突变:D148E MG MAGNESIUM ION × 1 PEG DI(HYDROXYETHYL)ETHER × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.89 Å R-free 0.223
6W0Q APE1 endonuclease product complex D148E 提交 2020-03-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:D148E EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.89 Å R-free 0.223
6W2P APE1 endonuclease product complex L104R 提交 2020-03-06 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
突变:L104R MG MAGNESIUM ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.94 Å R-free 0.238
6W2P APE1 endonuclease product complex L104R 提交 2020-03-06 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:L104R EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.94 Å R-free 0.238
6W3L APE1 exonuclease substrate complex wild-type 提交 2020-03-09 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
未记录 CA CALCIUM ION × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.59 Å R-free 0.277
6W3L APE1 exonuclease substrate complex wild-type 提交 2020-03-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
未记录 NA SODIUM ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.59 Å R-free 0.277
6W3N APE1 exonuclease substrate complex D148E 提交 2020-03-09 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:D148E CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.69 Å R-free 0.308
6W3N APE1 exonuclease substrate complex D148E 提交 2020-03-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
突变:D148E EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.69 Å R-free 0.308
6W3Q APE1 exonuclease substrate complex L104R 提交 2020-03-09 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:L104R NA SODIUM ION × 1 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.49 Å R-free 0.259
6W3Q APE1 exonuclease substrate complex L104R 提交 2020-03-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
突变:L104R 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.49 Å R-free 0.259
6W3U APE1 exonuclease substrate complex R237C 提交 2020-03-09 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:R237C CA CALCIUM ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.40 Å R-free 0.250
6W3U APE1 exonuclease substrate complex R237C 提交 2020-03-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
突变:R237C EDO 1,2-ETHANEDIOL × 1 NA SODIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;7% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.40 Å R-free 0.250
6W43 APE1 AP-endonuclease product complex R237C 提交 2020-03-10 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
突变:R237C EDO 1,2-ETHANEDIOL × 2 MG MAGNESIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.99 Å R-free 0.224
6W43 APE1 AP-endonuclease product complex R237C 提交 2020-03-10 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:R237C EDO 1,2-ETHANEDIOL × 2 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;10% PEG20000, 100 mM sodium citrate, pH 5.0, and 200 mM MgCl2
分辨率 1.99 Å R-free 0.224
6W4I APE1 Y269A product complex with abasic DNA 提交 2020-03-10 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
突变:Y269A, C138A MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;24% PEG 3350, 0.1 M Bis Tris Propane (pH 6.5), 0.2 M Sodium Fluoride
分辨率 2.20 Å R-free 0.227
6W4I APE1 Y269A product complex with abasic DNA 提交 2020-03-10 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:Y269A, C138A MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;24% PEG 3350, 0.1 M Bis Tris Propane (pH 6.5), 0.2 M Sodium Fluoride
分辨率 2.20 Å R-free 0.227
6W4T APE1 Y269A phosphorothioate substrate complex with abasic DNA 提交 2020-03-11 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 43–318(276 aa)
突变:Y269A, C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;27% PEG 3350, 100 mM Bis Tris Propane (pH 6.5), 200 mM Sodium Fluoride
分辨率 2.77 Å R-free 0.274
6W4T APE1 Y269A phosphorothioate substrate complex with abasic DNA 提交 2020-03-11 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 B 43–318(276 aa)
突变:Y269A, C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;27% PEG 3350, 100 mM Bis Tris Propane (pH 6.5), 200 mM Sodium Fluoride
分辨率 2.77 Å R-free 0.274
7LPG APE1 product complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;200 mM MgCl2, 100 mM Sodium Citrate (pH 5), 10-15% PEG 20,000
分辨率 2.08 Å R-free 0.263
7LPG APE1 product complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 D 43–318(276 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;200 mM MgCl2, 100 mM Sodium Citrate (pH 5), 10-15% PEG 20,000
分辨率 2.08 Å R-free 0.263
7LPH APE1 Mn-bound product complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;200 mM MgCl2, 100 mM Sodium Citrate (pH 5), 10-15% PEG 20,000
分辨率 1.99 Å R-free 0.237
7LPH APE1 Mn-bound product complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 D 43–318(276 aa)
突变:C138A MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;291 K;200 mM MgCl2, 100 mM Sodium Citrate (pH 5), 10-15% PEG 20,000
分辨率 1.99 Å R-free 0.237
7LPI APE1 phosphorothioate substrate complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;50 mM tri-Sodium Citrate (pH 4), 100 mM NaCl, 10% Peg 6,000
分辨率 2.05 Å R-free 0.245
7LPI APE1 phosphorothioate substrate complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 D 43–318(276 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;50 mM tri-Sodium Citrate (pH 4), 100 mM NaCl, 10% Peg 6,000
分辨率 2.05 Å R-free 0.245
7LPJ APE1 Mn-bound phosphorothioate substrate complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:C138A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;50 mM tri-Sodium Citrate (pH 4), 100 mM NaCl, 10% Peg 6,000
分辨率 2.56 Å R-free 0.248
7LPJ APE1 Mn-bound phosphorothioate substrate complex with abasic ribonucleotide DNA 提交 2021-02-11 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 D 43–318(276 aa)
突变:C138A MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;50 mM tri-Sodium Citrate (pH 4), 100 mM NaCl, 10% Peg 6,000
分辨率 2.56 Å R-free 0.248
7MCR Human Apex/Ref1 homodimer formed under oxidative condition 提交 2021-04-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 44–318(275 aa)
未记录 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;100 mM MES/ sodium hydroxide, 200 mM calcium acetate, 20% W/V PEG 8000
分辨率 1.90 Å R-free 0.233
7MEV Human Apex/Ref1 monomer with C138A mutation 提交 2021-04-07 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 44–318(275 aa)
突变:C138A MG MAGNESIUM ION × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;277.15 K;20 %w/v PEG 3350, 200 mM Sodium nitrate
分辨率 1.60 Å R-free 0.196
7SUV APE1 exonuclease substrate complex with 8oxoG opposite A 提交 2021-11-18 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:E96Q, C138A, D210N 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;293.15 K;7 - 14% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 1.99 Å R-free 0.265
7SUV APE1 exonuclease substrate complex with 8oxoG opposite A 提交 2021-11-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
突变:E96Q, C138A, D210N 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;293.15 K;7 - 14% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 1.99 Å R-free 0.265
7SVB APE1 exonuclease substrate complex with 8oxoG opposite C 提交 2021-11-18 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:E96Q, C138A, D210N 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;293.15 K;7 - 14% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.24 Å R-free 0.245
7SVB APE1 exonuclease substrate complex with 8oxoG opposite C 提交 2021-11-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–318(276 aa)
突变:E96Q, C138A, D210N 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;293.15 K;7 - 14% PEG20000, 100 mM sodium citrate, 15% glycerol, 5 mM calcium chloride
分辨率 2.24 Å R-free 0.245
7TC2 Human APE1 in complex with 5-nitroindole-2-carboxylic acid 提交 2021-12-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 39–318(280 aa)
未记录 GID 5-nitro-1H-indole-2-carboxylic acid × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;PEG3350, Sodium Formate
分辨率 1.43 Å R-free 0.270
7TC2 Human APE1 in complex with 5-nitroindole-2-carboxylic acid 提交 2021-12-22 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 39–318(280 aa)
未记录 GID 5-nitro-1H-indole-2-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;PEG3350, Sodium Formate
分辨率 1.43 Å R-free 0.270
7TC2 Human APE1 in complex with 5-nitroindole-2-carboxylic acid 提交 2021-12-22 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 39–318(280 aa)
未记录 GID 5-nitro-1H-indole-2-carboxylic acid × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;PEG3350, Sodium Formate
分辨率 1.43 Å R-free 0.270
7TC2 Human APE1 in complex with 5-nitroindole-2-carboxylic acid 提交 2021-12-22 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 39–318(280 aa)
未记录 GID 5-nitro-1H-indole-2-carboxylic acid × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;PEG3350, Sodium Formate
分辨率 1.43 Å R-free 0.270
7TC3 Human APE1 in the apo form 提交 2021-12-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 39–318(280 aa)
未记录 EDO 1,2-ETHANEDIOL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;PEG3350, Sodium Formate
分辨率 1.25 Å R-free 0.178
7TR7 APE1 product complex with abasic ssDNA 提交 2022-01-28 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:dimeric(2) 与全部聚合物一致
链 A 43–318(276 aa)
突变:C138A MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;0.05M KCl, 0.05M sodium cacodylate pH 6, 10% PEG 8,000, 5mM spermine, 5mM L-Argininamide dihydrochloride
分辨率 2.00 Å R-free 0.215
7TR7 APE1 product complex with abasic ssDNA 提交 2022-01-28 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:dimeric(2) 与全部聚合物一致
链 B 43–318(276 aa)
突变:C138A MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;0.05M KCl, 0.05M sodium cacodylate pH 6, 10% PEG 8,000, 5mM spermine, 5mM L-Argininamide dihydrochloride
分辨率 2.00 Å R-free 0.215
7U50 APE1 bound to a nucleosome core particle with AP-site at SHL-6 提交 2022-03-01 Assembly 1 蛋白–DNA 异源复合物;蛋白 × 9 PDB 声明:undecameric(11) 与全部聚合物一致
链 K 1–318(318 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
9DP1 APE1 N174A Substrate Complex with Abasic DNA 提交 2024-09-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 43–318(276 aa)
突变:tr1-42, C138A, N174A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;100 mM sodium citrate, pH 5.0, 200 mM magnesium chloride, 16-21% PEG20000
分辨率 2.29 Å R-free 0.251
9DP1 APE1 N174A Substrate Complex with Abasic DNA 提交 2024-09-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:tr1-42, C138A, N174A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;100 mM sodium citrate, pH 5.0, 200 mM magnesium chloride, 16-21% PEG20000
分辨率 2.29 Å R-free 0.251
9DP2 APE1 N174A Product Complex with Abasic DNA 提交 2024-09-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
突变:tr1-42, C138A, N174A MN MANGANESE (II) ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;100 mM sodium citrate, pH 5.0, 200 mM magnesium chloride, 16-21% PEG20000
分辨率 1.99 Å R-free 0.203
9DP2 APE1 N174A Product Complex with Abasic DNA 提交 2024-09-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:tr1-42, C138A, N174A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;100 mM sodium citrate, pH 5.0, 200 mM magnesium chloride, 16-21% PEG20000
分辨率 1.99 Å R-free 0.203
9DP3 APE1 N174D Product Complex with Abasic DNA 提交 2024-09-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
突变:tr1-42, C138A, N174D SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;200 mM lithium sulfate, 15-25% PEG3350
分辨率 2.10 Å R-free 0.274
9DP3 APE1 N174D Product Complex with Abasic DNA 提交 2024-09-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 43–318(276 aa)
突变:tr1-42, C138A, N174D 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;200 mM lithium sulfate, 15-25% PEG3350
分辨率 2.10 Å R-free 0.274
9DP4 APE1 N174Q Product Complex with Abasic DNA 提交 2024-09-20 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 43–318(276 aa)
突变:tr1-42, C138A, N174Q PEG DI(HYDROXYETHYL)ETHER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;100 mM HEPES free acid, 200 mM ammonium acetate, 25% PEG3350
分辨率 2.25 Å R-free 0.248
9DP4 APE1 N174Q Product Complex with Abasic DNA 提交 2024-09-20 Assembly 2 蛋白–DNA 单体;蛋白 × 1 PDB 声明:tetrameric(4) 与全部聚合物一致
链 B 43–318(276 aa)
突变:tr1-42, C138A, N174Q PEG DI(HYDROXYETHYL)ETHER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295 K;100 mM HEPES free acid, 200 mM ammonium acetate, 25% PEG3350
分辨率 2.25 Å R-free 0.248
9RQS Human APE1 in complex with DNA 提交 2025-06-26 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 39–318(280 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.15 M ammonium sulfate, 0.1 M Na HEPES pH 7, 20% w/v PEG 4000
分辨率 1.70 Å R-free 0.228